Xtl Biopharma ADR (XTLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2017 | 09-2017 | 06-2017 | 03-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,289 | 6,085 | 6,325 | 6,755 | 2,019 |
| Marketable Securities | 2,507 | 0 | 0 | N/A | 414 |
| Receivables | N/A | 0 | 0 | N/A | 321 |
| Other current assets | 410 | 359 | 467 | 651 | 0 |
| TOTAL | $6,206 | $6,444 | $6,792 | $7,406 | $2,754 |
| Non-Current Assets | |||||
| PPE Net | N/A | 0 | 0 | N/A | 10 |
| Intangibles | 0 | 0 | 0 | 0 | 253 |
| Other Non-Current Assets | 380 | 381 | 380 | 390 | 0 |
| TOTAL | $380 | $381 | $380 | $390 | $263 |
| Total Assets | $6,586 | $6,825 | $7,172 | $7,796 | $3,017 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 0 | 0 | 0 | 0 | 330 |
| TOTAL | $300 | $286 | $382 | $N/A | $330 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 2,667 | 2,919 | 4,700 | 0 | 0 |
| TOTAL | $2,667 | $2,919 | $4,700 | $N/A | $N/A |
| Total Liabilities | $2,967 | $3,205 | $5,082 | $4,294 | $330 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 5,142 | N/A | N/A | N/A | N/A |
| Common Shares | N/A | 13,182 | 13,182 | N/A | 6,624 |
| Retained earnings | N/A | -155,651 | -157,240 | N/A | -154,904 |
| Other shareholders' equity | 3,619 | 86 | 145 | 3,502 | 183 |
| TOTAL | $3,619 | $3,620 | $2,090 | $3,502 | $2,687 |
| Total Liabilities And Equity | $6,586 | $6,825 | $7,172 | $7,796 | $3,017 |